Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 4 |
2023 | 1 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.
Cancer Res. 2024 Mar 15;84(6):855-871. doi: 10.1158/0008-5472.CAN-23-0966.
Cancer Res. 2024.
PMID: 38486485
Loss of ESRP2 Activates TAK1-MAPK Signaling through the Fetal RNA-Splicing Program to Promote Hepatocellular Carcinoma Progression.
Yan Q, Fang X, Liu X, Guo S, Chen S, Luo M, Lan P, Guan XY.
Yan Q, et al.
Adv Sci (Weinh). 2024 Jan;11(1):e2305653. doi: 10.1002/advs.202305653. Epub 2023 Nov 20.
Adv Sci (Weinh). 2024.
PMID: 37985644
Free PMC article.
Item in Clipboard
Immune related biomarkers for cancer metastasis to the brain.
Chen WW, Chu TSM, Xu L, Zhao CN, Poon WS, Leung GK, Kong FS.
Chen WW, et al.
Exp Hematol Oncol. 2022 Dec 16;11(1):105. doi: 10.1186/s40164-022-00349-z.
Exp Hematol Oncol. 2022.
PMID: 36527157
Free PMC article.
Review.
Item in Clipboard
Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.
Fang X, Yan Q, Liu S, Guan XY.
Fang X, et al.
Int J Mol Sci. 2022 Oct 14;23(20):12327. doi: 10.3390/ijms232012327.
Int J Mol Sci. 2022.
PMID: 36293184
Free PMC article.
Review.
Item in Clipboard
Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.
Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, Zhao C, Yang L, Xu Z, Dong S, Yu H, Li B, Guan X, Hou Y, Kong FM.
Xu L, et al.
J Hematol Oncol. 2022 Jul 7;15(1):87. doi: 10.1186/s13045-022-01307-2.
J Hematol Oncol. 2022.
PMID: 35799264
Free PMC article.
Review.
Item in Clipboard
MAEL Augments Cancer Stemness Properties and Resistance to Sorafenib in Hepatocellular Carcinoma through the PTGS2/AKT/STAT3 Axis.
Shi C, Kwong DL, Li X, Wang X, Fang X, Sun L, Tang Y, Guan XY, Li SS.
Shi C, et al.
Cancers (Basel). 2022 Jun 10;14(12):2880. doi: 10.3390/cancers14122880.
Cancers (Basel). 2022.
PMID: 35740546
Free PMC article.
Item in Clipboard
Cite
Cite